Registration Statement No. 333 -
AKAZOO S.A.
(Exact name of registrant as specified in
its charter)
|
Luxembourg
|
|
N/A
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
Akazoo S.A.
|
|
C
T Corporation System
|
One Heddon Street
W1B 4BD, London, UK
+44 20 8057 6555
(Address and telephone number of
Registrant’s principal executive offices)
|
|
28 Liberty Street
New York, New York 10005
(877) 467-3525
(Name, address and telephone number of
agent for service)
|
|
|
|
|
|
|
Copies to:
|
|
|
|
Mark L. Hanson, Esq.
Jones Day
1420 Peachtree Street, N.E., Suite 800
Atlanta, Georgia 30309
Tel: (404) 521-3939
|
|
Approximate date of
commencement of proposed sale to the public: From time to time after this registration statement becomes effective as determined
by market conditions and other factors.
If the only securities
being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following
box. ¨
If any of the securities
being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, check the following box. x
If this Form is filed
to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
¨
If this Form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. ¨
If this Form is a registration
statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with
the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ¨
If this Form is a post-effective
amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ¨
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933. x
If an emerging growth
company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected
not to use the extended transition period for complying with any new or revised financial accounting standards† provided
pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
†The term “new
or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its
Accounting Standards Codification after April 5, 2012.
CALCULATION OF REGISTRATION
FEE
|
Title of Each Class of Securities to be Registered
|
|
Amount to be
Registered (1)
|
|
Proposed Per Unit
Offering Price
|
|
|
Proposed Maximum
Aggregate Offering
Price
|
|
|
Amount of
Registration Fee
|
|
|
Ordinary Shares, nominal value €0.01 per share, to be offered by the Selling Securityholders
|
|
310,000
|
|
$
|
2.02 (2)
|
|
|
$
|
626,200
|
|
|
$
|
81.28
|
|
|
Warrants to purchase Ordinary Shares, to be offered by the Selling Securityholders
|
|
150,000
|
|
|
(3)
|
|
|
|
(3)
|
|
|
|
(3)
|
|
|
Ordinary Shares underlying the Warrants
|
|
150,000
|
|
$
|
11.22 (3)
|
|
|
$
|
1,683,000
|
|
|
$
|
218.45
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
$
|
299.73
|
|
|
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended, the ordinary shares being registered
hereunder include such indeterminate amount of shares as may be issuable as a result of stock splits, stock dividends or similar
transactions.
|
|
|
(2)
|
Calculated pursuant to Rule 457(c), using the average of the high and low trading prices of Ordinary
Shares on March 20, 2020 on the Nasdaq Capital Market.
|
|
|
(3)
|
Calculated by analogy to Rule 457(i), using the exercise price of the Warrants and the proposed
offering price of the Ordinary Shares underlying the Warrants, calculated pursuant to Rule 457(c). As required by Rule 457(i),
solely for purposes of calculating this registration fee, the entire offering price for the Warrants and Ordinary Shares underlying
the Warrants is allocated to the Ordinary Shares underlying the Warrants.
|
The Registrant hereby
amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance
with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such
date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
THE INFORMATION IN THIS
PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING
AN OFFER TO BUY OR SELL THESE SECURITIES IN ANY JURISDICTION WHERE THE OFFER OR SALE IS NOT PERMITTED. THESE SECURITIES MAY NOT
BE SOLD UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE.
PRELIMINARY
PROSPECTUS
Subject to completion, dated March 25,
2020
Up to 310,000 Ordinary Shares,
Up to 150,000 Warrants to Purchase Ordinary Shares at an Exercise Price of $9.20 per Ordinary Share and
Up to 150,000 Ordinary
Shares Issuable upon Exercise of the Warrants
Offered by the Selling Securityholders of
AKAZOO S.A.
This prospectus relates
to the resale from time to time of up to 310,000 ordinary shares of Akazoo S.A. (the “Company”), par value €0.01
per share (the “Outstanding Ordinary Shares”), up to 150,000 warrants to purchase ordinary shares of the Company at
an exercise price of $9.20 per ordinary share (the “Warrants”) and up to 150,000 ordinary shares of the Company issuable
upon exercise of the Warrants (the “Issuable Ordinary Shares” and, together with the Outstanding Ordinary Shares, the
“Ordinary Shares”).
The selling securityholders
named in this prospectus, or their respective donees, pledgees, transferees, distributees, designees or other successors in interest
(collectively, the “Selling Securityholders”), may sell, in one or more offerings pursuant to this prospectus, these
Ordinary Shares and Warrants from time to time on or off the Nasdaq Capital Market (“Nasdaq”) in regular brokerage
transactions, in transactions directly with market makers or in privately negotiated transactions.
Information on the
Selling Securityholders and the times and manners in which they may offer and sell the Ordinary Shares and Warrants are described
under the sections entitled “Selling Securityholders” and “Plan of Distribution” in this prospectus.
The Company will not
receive any of the proceeds from the sale of Ordinary Shares or Warrants but could receive up to approximately $1,380,000 from
the exercise of the Warrants if the Warrants are exercised for cash by the holders thereof. The Company intends to use any proceeds
received from the exercise of the Warrants for working capital and other general corporate purposes. The Company, however, cannot
assure you that any of the Warrants will be exercised.
The Ordinary Shares
are currently traded on Nasdaq under the symbol “SONG.” We do not expect the Warrants to be traded on any national
securities exchange.
An investment in
these securities involves risks. See the section entitled “Risk Factors” on page 5 of this prospectus, and other
risk factors contained in any applicable prospectus supplement and in the documents incorporated by reference herein and therein.
Neither the U.S.
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2020.
Table
of Contents
ABOUT
THIS PROSPECTUS
On September 11, 2019,
Akazoo S.A., a Luxembourg public limited company (société anonyme) (“Akazoo,” “we,”
“us,” “our” and the “Company”), completed a series of transactions (the “Business Combination”)
that combined the businesses and assets of Modern Media Acquisition Corp. (“MMAC”) and Akazoo Limited (“Old Akazoo”)
pursuant to a Business Transaction Agreement, dated as of January 24, 2019 (as amended from time to time, the “Business Transaction
Agreement”). Immediately following the Business Combination, the Company completed a private placement offering pursuant
to which certain private investors purchased Ordinary Shares and Warrants for cash. In addition, in connection with the completion
of the Business Combination and private placement offering, the Company issued Ordinary Shares to certain entities in satisfaction
of certain amounts owed by MMAC.
This prospectus is
part of a registration statement on Form F-3 that the Company filed with the Securities and Exchange Commission (the “Commission”)
using a “shelf” registration process. Under this shelf registration process, the Selling Securityholders may, from
time to time sell the Ordinary Shares and Warrants in one or more offerings pursuant to this registration statement, or any combination
of the securities described in this prospectus. The Selling Securityholders may use the shelf registration statement to sell up
to up to an aggregate of 310,000 Ordinary Shares and 150,000 Warrants that were previously acquired by the Selling Securityholders
from the Company. This prospectus also relates to the issuance by the Company of up to 150,000 Ordinary Shares issuable upon exercise
of the Warrants.
The Company will not
receive any proceeds from the sale of Ordinary Shares or Warrants to be offered by the Selling Securityholders pursuant to this
prospectus, but the Company will receive proceeds from Warrants exercised in the event that such Warrants are exercised for cash.
The Company will pay the expenses, other than underwriting discounts and commissions, if any, associated with the sale of Ordinary
Shares and Warrants pursuant to this prospectus. To the extent required, the Company and the Selling Securityholders, as applicable,
will deliver a prospectus supplement with this prospectus to update the information contained in this prospectus. The prospectus
supplement may also add, update or change information included in this prospectus. You should read both this prospectus and any
applicable prospectus supplement, together with additional information described below under the captions “Where You Can
Find Additional Information.”
You should rely only
on the information contained or incorporated by reference in this prospectus and in any prospectus supplement. Neither the Company
nor the Selling Securityholders have authorized any other person to provide you with different information. If anyone provides
you with different or inconsistent information, you should not rely on it. The Selling Securityholders will not make any offer
to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing
in this prospectus and, if applicable, the supplement to this prospectus is accurate as of the date on its respective cover, and
that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless
indicated otherwise. The Company’s business, financial condition, results of operations and prospects may have changed since
those dates.
PROSPECTUS
SUMMARY
This summary is
qualified in its entirety by the more detailed information and financial statements included or incorporated by reference elsewhere
in this prospectus. This summary may not contain all of the information that may be important to you. As an investor or prospective
investor, you should carefully review the entire prospectus, including the section of this prospectus entitled “Risk Factors”
beginning on page 5 and the more detailed information that appears later in this prospectus or is contained in the documents
that we incorporate by reference into this prospectus before making an investment in our securities.
The Company
Akazoo S.A., a Luxembourg
public limited company (société anonyme) (formerly known as Modern Media Acquisition Corp. S.A.), was incorporated
on February 6, 2019 with our registered office at 19 Rue de Bitbourg, 1273 Luxembourg.
On September 11, 2019,
the parties to the Business Transaction Agreement completed the Business Combination, which combined the assets and businesses
of MMAC and Old Akazoo into the Company, with the Company continuing as a publicly traded entity. The Business Combination resulted
in (1) stockholders of MMAC, equityholders of Old Akazoo, certain other equity investors and certain creditors of MMAC together
holding all of the outstanding Ordinary Shares, warrants to purchase Ordinary Shares at an exercise price of $11.50 and warrants
to purchase Ordinary Shares at an exercise price of $9.20 and (2) Old Akazoo becoming a wholly owned subsidiary of Akazoo.
In connection with
the completion of the Business Combination, we completed a private placement offering of Ordinary Shares and Warrants to certain
private investors that raised an aggregate of approximately $40.6 million.
Our principal operational
office is located at One Heddon Street, W1B 4BD, London, United Kingdom, and our telephone number is +44 20 8057 6555. Our website
is www.akazoo.com. The information contained on our website is not incorporated by reference into this prospectus and you should
not consider information contained on our website to be part of this prospectus.
Nasdaq Listing
The Ordinary Shares
are listed on Nasdaq under the symbol “SONG”. We currently do not plan to apply to list the Warrants on any national
securities exchange.
The Securities the
Selling Securityholders May Offer
The Selling Securityholders
may sell, in one or more offerings pursuant to this prospectus, up to the number of Ordinary Shares and Warrants listed on the
cover page of this prospectus, which Ordinary Shares and Warrants were previously acquired by the Selling Securityholders from
the Company. We will not receive any of the proceeds from the sale of Ordinary Shares or Warrants by the Selling Securityholders.
THE
OFFERING
The following summary
of the offering contains basic information about the offering, our Ordinary Shares and the Warrants and is not intended to be complete.
It does not contain all the information that may be important to you. For a more complete understanding of our Ordinary Shares
and Warrants, please refer to the section of this prospectus entitled “Description of Securities.”
|
Maximum number of Ordinary Shares Offered by the Selling Securityholders
|
310,000 Ordinary Shares
|
|
Maximum number of Warrants Offered by the Selling Securityholders
|
150,000 Warrants
|
|
Shares issuable upon exercise or conversion of Warrants Offered by the Selling Securityholders
|
150,000 Issuable Ordinary Shares underlying Warrants
|
|
Ordinary Shares Issued and Outstanding
|
49,735,210 ordinary shares
|
|
Use of Proceeds
|
All Ordinary Shares and Warrants sold pursuant to this prospectus will be sold by the Selling Securityholders. We will not receive any of the proceeds from such sales. However, we could receive up to approximately $1,380,000 from the exercise for cash of the Warrants for Issuable Ordinary Shares. We intend to use any proceeds received from the exercise of the Warrants for working capital and other general corporate purposes. We cannot assure you that any of the Warrants will be exercised.
|
|
Nasdasq Capital Market Trading Symbol for Ordinary Shares
|
“SONG”
|
|
Risk Factors
|
An investment in our Ordinary Shares and Warrants involves certain risks. You should carefully consider the risks described under “Risk Factors” on page 5 of this prospectus, as well risk factors and other information included in or incorporated by reference herein and therein before making an investment decision.
|
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains
a number of forward-looking statements, including statements about our financial conditions, results of operations, earnings outlook
and prospects. In addition, any statements that refer to projections, forecasts or other characterizations of future events or
circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified
by words such as “plan,” “believe,” “expect,” “anticipate,” “intend,”
“outlook,” “estimate,” “forecast,” “project,” “continue,” “could,”
“may,” “might,” “possible,” “potential,” “predict,” “should,”
“would” and other similar words and expressions, but the absence of these words does not mean that a statement is not
forward-looking.
The forward-looking
statements are based on the current expectations of management and are inherently subject to uncertainties and changes in circumstance
and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments
will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking
statements. These risks and uncertainties include, but are not limited to, those factors described in “Risk Factors,”
those discussed and identified in our public filings made with the Commission and the following:
|
|
·
|
expectations regarding our strategies and future financial performance, including our future business
plans or objectives, prospective performance and opportunities, and competitors, revenues, customer acquisition and retention,
products and services, pricing, marketing plans, operating expenses, market trends, liquidity, cash flows and uses of cash, capital
expenditures, and our ability to maintain access to content and manage license relationships, and to invest in growth initiatives
and pursue acquisition opportunities;
|
|
|
·
|
the ability to recognize the anticipated benefits of the Business Combination;
|
|
|
·
|
the concentration of voting power among our major securityholders who have substantial control
over our ordinary shares;
|
|
|
·
|
the limited liquidity and trading of our securities;
|
|
|
·
|
geopolitical risk and changes in applicable laws or regulations in our varying markets;
|
|
|
·
|
the possibility that we may be adversely affected by other economic, business, and/or competitive
factors;
|
|
|
·
|
litigation and regulatory enforcement risks, including the diversion of management time and attention
and the additional costs and demands on our resources; and
|
|
|
·
|
fluctuations in exchange rates between the foreign currencies in which we typically do business
and the Euro.
|
Should one or more
of these risks or uncertainties materialize, or should any of the assumptions made by management prove incorrect, actual results
may vary in material respects from those projected in these forward-looking statements.
All subsequent written
and oral forward-looking statements concerning matters addressed in this prospectus and attributable to us or any person acting
on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this prospectus.
Except to the extent required by applicable law or regulation, we undertake no obligation to update these forward-looking statements
to reflect events or circumstances after the date of this prospectus or to reflect the occurrence of unanticipated events.
RISK
FACTORS
An investment in
our securities involves a high degree of risk. Before making an investment in our securities, you should carefully consider all
of the information included in this prospectus, the risk factors presented in Item 3.D. of our Shell Company Report on Form 20-F,
filed with the Commission on September 17, 2019, which are incorporated herein by reference, and all of the other information included
in any prospectus supplement and other documents that have been incorporated by reference in this prospectus and any prospectus
supplement, as well in our other filings with the Commission. Please see the section of this prospectus entitled “Where You
Can Find Additional Information— Information Incorporated by Reference.” The occurrence of one or more of those risk
factors could adversely impact our business, financial condition or results of operations.
USE
OF PROCEEDS
We will not receive
any proceeds from sales of our Ordinary Shares or Warrants by the Selling Securityholders. However, we could receive up to approximately
$1,380,000 from the exercise for cash of the Warrants for the Issuable Ordinary Shares that are presently offered under this prospectus
if such Warrants are exercised by the holders thereof. We intend to use any proceeds received from the exercise of the Warrants
for working capital and other general corporate purposes. We cannot assure you that any of the Warrants will be exercised.
CAPITALIZATION
The material presented
under the heading “Interim Condensed Consolidated Statement of Financial Position” and the related notes thereto, included
in our Report on Form 6-K filed with the Commission on September 27, 2019, is incorporated herein by reference.
DESCRIPTION
OF SECURITIES
Authorized and Outstanding
Capital Stock
We were incorporated
as a Luxembourg public company on February 6, 2019 with an issued share capital of €30,000, represented by 3,000,000 Ordinary
Shares. All shares were fully paid and subscribed for. Until the consummation of the Business Combination, we did not have any
authorized capital.
On September 2, 2019,
the Akazoo shareholders resolved, in connection with the Business Combination, that the 3,000,000 Ordinary Shares outstanding would
be cancelled and our share capital would be reduced by €30,000 effective as of the Business Combination. Subsequently, in
connection with the Business Combination, our share capital was increased to provide for issuances of Ordinary Shares to equityholders
of MMAC and Old Akazoo in the Business Combination. Subsequently, in connection with the private placement offering and the transactions
contemplated thereby, a delegate of the Akazoo Board of Directors increased our share capital. After such increases, and the repurchase
of 2,600,000 Ordinary Shares discussed below, our share capital was €497,352.10. Ordinary Shares and Warrants sold in the
private placement offering were sold as part of Akazoo Units, which were sold to certain private investors at a price of $8.00
per Unit. Ordinary Shares were also issued in connection with the private placement offering to certain creditors of MMAC in lieu
of cash payment by Akazoo of amounts owed to them. Such Ordinary Shares were issued to those creditors at a rate of $8.00 of amounts
payable per Ordinary Share. Furthermore, in connection with the Business Combination and the private placement offering, Akazoo
repurchased an aggregate of 2,600,000 Ordinary Shares from certain securityholders of Akazoo and such Ordinary Shares were cancelled
by the resolutions of the delegate of the Akazoo Board of Directors.
As of March 25,
2020, our issued share capital amounted to €497,352.10, represented by ordinary shares with a nominal value of €0.01
per share. All issued shares are fully paid and subscribed for. A shareholder in a Luxembourg société anonyme holding
fully paid up shares is not liable, solely because of his or her or its shareholder status, for additional payments to us or our
creditors.
We currently have
€9,925,107.67 of authorized capital, represented by 992,510,767 ordinary shares with a nominal value of €0.01 per share.
Authority to issue share capital from our authorized capital will expire on September 2, 2024.
As of March 25,
2020, we held no ordinary shares as treasury shares.
As of March 25,
2020, Akazoo Public Warrants to purchase 10,349,997 Ordinary Shares at an exercise price of $11.50 were issued and outstanding.
As of March 25,
2020, Warrants to purchase 7,320,000 Ordinary Shares at an exercise price of $9.20 were issued and outstanding.
Description of Akazoo
Articles of Association.
The material presented
in Item 10.B. of our Shell Company Report on Form 20-F, filed with the Commission on September 17, 2019, is incorporated herein
by reference.
Description of Akazoo
Ordinary Shares
The material presented
in our joint proxy statement/prospectus on Form F-4 filed with the Commission on August 14, 2019 under the headings “Description
of PubCo Share Capital, Warrants and Articles of Association – Issuance of Ordinary Shares and Preemptive Rights,”
“– Repurchase of Ordinary Shares,” “– Form and Transfer of Ordinary Shares,” “–
Liquidation Rights and Dissolution,” “– Voting Rights,” and “–Dividend Rights” are incorporated
herein by reference.
Description of Akazoo
Warrants
Akazoo is registering
Warrants to purchase 150,000 Ordinary Shares. Each Warrant entitles the registered holder to purchase one Ordinary Share at a price
of $9.20 per share, subject to adjustment as discussed below, pursuant to the terms of the applicable warrant agreement. The Warrants
will expire at 5:00 p.m., New York City time, five years after issuance or earlier upon Akazoo’s redemption or liquidation.
If Ordinary Shares
are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition
of a “covered security” under Section 18(b)(1) of the Securities Act, Akazoo may, at its option, require holders of
Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities
Act and, in the event Akazoo so elects, Akazoo will not be required to file or maintain in effect a registration statement, but
will use its best efforts to qualify the Ordinary Shares issuable upon exercise of the Warrants under applicable blue sky laws
to the extent an exemption is not available.
Once the Warrants
become exercisable, Akazoo may call the Warrants for redemption:
|
|
·
|
in whole and not in part;
|
|
|
·
|
at a price of $0.01 per Warrant;
|
|
|
·
|
upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period,
to each Warrant holder; and
|
|
|
·
|
if, and only if, the last reported closing price of the Ordinary Shares equals or exceeds $18.00
per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading
days within a 30-trading day period ending on the third trading day prior to the date on which Akazoo sends the notice of redemption
to the Warrant holders.
|
Akazoo will not redeem
the Warrants unless an effective registration statement under the Securities Act covering the Ordinary Shares issuable upon exercise
of the Warrants is effective and a current prospectus relating to those Ordinary Shares is available throughout the 30-day redemption
period, except if the Warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under
the Securities Act.
Akazoo has established
the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant
premium to the Warrant exercise price. If the foregoing conditions are satisfied and Akazoo issues a notice of redemption of the
Warrants, each Warrant holder will be entitled to exercise his, her or its Warrant prior to the scheduled redemption date. However,
the price of the Ordinary Shares may fall below the $18.00 redemption trigger price as well as the $9.20 Warrant exercise price
after the redemption notice is issued.
If Akazoo calls the
Warrants for redemption as described above, its management will have the option to require all holders that wish to exercise Warrants
to do so on a “cashless basis.” In determining whether to require all holders to exercise their Warrants on a “cashless
basis,” management will consider, among other factors, its cash position, the number of Warrants that are outstanding and
the dilutive effect on holders of Ordinary Shares of issuing the maximum number of Ordinary Shares issuable upon the exercise of
the Warrants. If management takes advantage of this option, each holder would pay the exercise price by surrendering the Warrants
for that number of Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Ordinary Shares
underlying the Warrants, multiplied by the difference between the exercise price of the Warrants and the “fair market value”
(defined below) by (y) the fair market value. The “fair market value” will mean the average reported last closing price
of the Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption
is sent to the holders of Warrants. If management takes advantage of this option, the notice of redemption will contain the information
necessary to calculate the number of Ordinary Shares to be received upon exercise of the Warrants, including the “fair market
value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby
lessen the dilutive effect of a Warrant redemption. Akazoo believes this feature is an attractive option to it if Akazoo does not
need the cash from the exercise of the Warrants.
A holder of a Warrant
may notify Akazoo in writing in the event it elects to be subject to a requirement that such holder will not have the right to
exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s
affiliates), to the Warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a
holder may specify) of the Ordinary Shares outstanding immediately after giving effect to such exercise.
If the number of outstanding
Ordinary Shares is increased by a capitalization or stock dividend payable in Ordinary Shares, or by a split-up of Ordinary Shares
or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of Ordinary Shares
issuable on exercise of each Warrant will be increased in proportion to such increase in the outstanding Ordinary Shares. A rights
offering to holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than the fair market value
will be deemed a stock dividend of a number of Ordinary Shares equal to the product of (i) the number of Ordinary Shares actually
sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into
or exercisable for Ordinary Shares) multiplied by (ii) one (1) minus the quotient of (x) the price per Ordinary Share paid in such
rights offering divided by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible
into or exercisable for Ordinary Shares, in determining the price payable for Ordinary Shares, there will be taken into account
any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair
market value means the volume weighted average price of Ordinary Shares as reported during the ten trading day period ending on
the trading day prior to the first date on which the Ordinary Shares trade on the applicable exchange or in the applicable market,
regular way, without the right to receive such rights.
In addition, if Akazoo,
at any time while the Warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other
assets to the holders of Ordinary Shares on account of such shares, other than: (i) as described above or (ii) certain ordinary
cash dividends, then the Warrant exercise price will be decreased, effective immediately after the effective date of such event,
by the amount of cash and/or the fair market value (as determined by the board of directors in good faith) of any securities or
other assets paid on each Ordinary Share in respect of such event.
If the number of outstanding
Ordinary Shares is decreased by a consolidation, combination, reverse stock split or reclassification of Ordinary Shares or other
similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar
event, the number of Ordinary Shares issuable on exercise of each Warrant will be decreased in proportion to such decrease in outstanding
Ordinary Shares.
Whenever the number
of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted, as described above, the Warrant exercise price will
be adjusted by multiplying the Warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which
will be the number of Ordinary Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y)
the denominator of which will be the number of Ordinary Shares so purchasable immediately thereafter.
In case of any reclassification
or reorganization of the outstanding Ordinary Shares (other than those described above or that solely affects the par value of
such Ordinary Shares), or in the case of any merger or consolidation of Akazoo with or into another corporation (other than a consolidation
or merger in which Akazoo is the continuing corporation and that does not result in any reclassification or reorganization of the
outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other
property of Akazoo as an entirety or substantially as an entirety in connection with which Akazoo is dissolved, the holders of
the Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified
in the Warrants and in lieu of the Ordinary Shares immediately theretofore purchasable and receivable upon the exercise of the
rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
that the holder of the Warrants would have received if such holder had exercised their Warrants immediately prior to such event.
However, (i) if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other
assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each
Warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders
in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer has been
made to and accepted by such holders under circumstances in which, upon completion of such tender or exchange offer, the maker
thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker
is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act)
and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule
13d-3 under the Exchange Act) more than 50% of the outstanding Ordinary Shares, the holder of a Warrant will be entitled to receive
the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder
if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer
and all of the shares of common stock held by such holder had been purchased pursuant to such tender or exchange offer, subject
to adjustments (from and after the completion of such tender or exchange offer) as nearly equivalent as possible to the adjustments
provided for in the warrant agreement. Additionally, if less than 70% of the consideration receivable by the holders of the Ordinary
Shares in such a transaction is payable in the form of common stock in the successor entity that is listed for trading on a national
securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately
following such event, and if the registered holder of the Warrant properly exercises the Warrant within thirty days following public
disclosure of such transaction, the Warrant exercise price will be reduced as specified in the warrant agreement based on the per
share consideration minus Black-Scholes Warrant Value (as defined in the warrant agreement) of the Warrant.
The Warrants will
be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent,
and Akazoo. The warrant agreement will provide that the terms of the Warrants may be amended without the consent of any holder
to cure any ambiguity or correct any defective provision, but will require the approval of the holders of at least 65% of the then-outstanding
public Warrants to make any change that adversely affects the interests of the registered holders of the Warrants.
The Warrants may be
exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with
the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment
of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to Akazoo, for the number
of Warrants being exercised. The Warrant holders will not have the rights or privileges of holders of Ordinary Shares or any voting
rights until they exercise their Warrants and receive Ordinary Shares. After the issuance of Ordinary Shares upon exercise of the
Warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.
TAX
The material presented
in Item 10.E. of our Shell Company Report on Form 20-F, filed with the Commission on September 17, 2019, is incorporated herein
by reference.
ENFORCEMENT
OF CIVIL LIABILITIES UNDER U.S. SECURITIES LAWS
Akazoo is a public
limited liability company (société anonyme or S.A.) organized under the laws of the Grand Duchy of Luxembourg. Most
of the members of the board of directors, its senior management and the experts named in this prospectus reside outside the United
States and a substantial portion of their assets are located outside the United States. As a result, it may not be possible to
effect service of process within the United States upon these individuals or upon Akazoo or to enforce judgments obtained in U.S.
courts based on the civil liability provisions of the U.S. securities laws against Akazoo in the United States. Awards of punitive
damages in actions brought in the United States or elsewhere are generally not enforceable in Luxembourg and penalty clauses and
similar clauses on damages or liquidated damages are allowed to the extent that they provide for a reasonable level of damages
and the courts of Luxembourg have the right to reduce or increase the amount thereof if it is unreasonably high or low.
As there is no treaty
in force on the reciprocal recognition and enforcement of judgments in civil and commercial matters between the United States and
the Grand Duchy of Luxembourg, courts in Luxembourg will not automatically recognize and enforce a final judgment rendered by a
U.S. court. A valid judgment obtained from a court of competent jurisdiction in the United States may be entered and enforced through
a court of competent jurisdiction in Luxembourg, subject to compliance with the enforcement procedures (exequatur). The enforceability
in Luxembourg courts of judgments rendered by U.S. courts will be subject, prior to any enforcement in Luxembourg, to the procedure
and the conditions set forth in the Luxembourg procedural code, which conditions may include that as of the date of this proxy
statement/prospectus (which may change):
|
|
·
|
the judgment of the U.S. court is final and enforceable (exécutoire) in the United States;
|
|
|
·
|
the U.S. court had jurisdiction over the subject matter leading to the judgment (that is, its jurisdiction
was in compliance both with Luxembourg private international law rules and with the applicable domestic U.S. federal or state jurisdictional
rules);
|
|
|
·
|
the U.S. court has applied to the dispute the substantive law that would have been applied by Luxembourg
courts. Based on recent case law and legal doctrine, it is not certain that this condition would still be required for an exequatur
to be granted by a Luxembourg court;
|
|
|
·
|
the judgment was granted following proceedings where the counterparty had the opportunity to appear
and, if it appeared, to present a defense, and the decision of the foreign court must not have been obtained by fraud, but in compliance
with the rights of the defendant;
|
|
|
·
|
the U.S. court has acted in accordance with its own procedural laws; and
|
|
|
·
|
the decisions and the considerations of the U.S. court must not be contrary to Luxembourg international
public policy rules or have been given in proceedings of a tax or criminal nature or rendered subsequent to an evasion of Luxembourg
law (fraude a la loi). It cannot be excluded that awards of damages made under civil liabilities provisions of the U.S. federal
securities laws, or other laws, which are classified by Luxembourg courts as being of a penal or punitive nature (for example,
fines or punitive damages, would not be recognized by Luxembourg courts). Ordinarily an award of monetary damages would not be
considered as a penalty, but if the monetary damages include punitive damages such punitive damages may be considered as a penalty.
|
In addition, actions
brought in a Luxembourg court against Akazoo or the members of the board of directors, its other officers and the experts named
herein to enforce liabilities based on U.S. federal securities laws may be subject to certain restrictions. In particular, Luxembourg
courts do generally not award punitive damages. Litigation in Luxembourg also is subject to rules of procedure that differ from
the U.S. rules, including with respect to the taking and admissibility of evidence, the conduct of the proceedings and the allocation
of costs. Proceedings in Luxembourg would have to be conducted in the French or German language, and all documents submitted to
the court would, in principle, have to be translated into French or German.
There exists no published
case law in Luxembourg in relation to the recognition of limited recourse provisions by which a party agrees to limit its recourse
against the other party to the assets available at any given point in time with such other party and there exists no published
case law in Luxembourg in relation to the recognition of foreign law governed subordination provisions whereby a party agrees to
subordinate its claims of another party. If a Luxembourg court had to analyze the enforceability of such provisions, it is likely
that it would consider the position taken by Belgian and Luxembourg legal scholars according to which limited recourse provisions
are enforceable against the parties thereto but not against third parties.
A contractual provision
allowing the service of process against a party to a service agent could be overridden by Luxembourg statutory provisions allowing
the valid serving of process against a party subject to and in accordance with the laws of the country where such party is domiciled.
For these reasons,
it may be difficult for a U.S. investor to bring an original action in a Luxembourg court predicated upon the civil liability provisions
of the U.S. federal securities laws against us, the members of the board of directors and other senior management and the experts
named in this prospectus. In addition, even if a judgment against Akazoo, the non-U.S. members of its board of directors, senior
management, or the experts named in this proxy statement/prospectus based on the civil liability provisions of the U.S. federal
securities laws is obtained, a U.S. investor may not be able to enforce it in U.S. or Luxembourg courts.
PLAN
OF DISTRIBUTION
The Selling Securityholders
may, from time to time, sell, transfer or otherwise dispose of any or all of the Ordinary Shares and Warrants held by them, including
on any stock exchange, quotation service, market or other trading facility on which our Ordinary Shares and Warrants are listed
or traded, in the over-the-counter market, through underwriters, through agents, to dealers, or in private transactions, at fixed
prices, at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at varying prices (which
may be above or below market prices prevailing at the time of sale), at negotiated prices or otherwise.
The Selling Securityholders
may use any one or more of the following methods when disposing of Ordinary Shares, Warrants or interests therein:
|
|
·
|
ordinary brokerage transactions and transactions in which a broker-dealer solicits purchasers;
|
|
|
·
|
block trades in which a broker-dealer will attempt to sell the common shares as agent, but may
position and resell a portion of the block as principal to facilitate the transaction;
|
|
|
·
|
purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
|
|
|
·
|
an exchange distribution in accordance with the rules of the applicable exchange;
|
|
|
·
|
privately negotiated transactions;
|
|
|
·
|
through the writing or settlement of options or other hedging transactions, whether through an
options exchange or otherwise;
|
|
|
·
|
broker-dealers may agree with the Selling Securityholders to sell a specified number of common
shares at a stipulated price per share;
|
|
|
·
|
a distribution by way of a dividend or otherwise to existing securityholders of such Selling Securityholders;
|
|
|
·
|
a combination of any such methods of sale; and
|
|
|
·
|
any other method permitted pursuant to applicable law.
|
The Selling Securityholders
may, from time to time, pledge or grant a security interest in some or all of the Ordinary Shares or Warrants owned by them and,
if such Selling Securityholder defaults in the performance of its secured obligations, the pledgees or secured parties may offer
and sell the Ordinary Shares or Warrants, as applicable from time to time, under this prospectus, or under an amendment to this
prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, amending the list of Selling Securityholders
to include the donees, pledgees, transferees, distributees, designees or other successors in interest as Selling Securityholders
under this prospectus. The Selling Securityholders also may transfer the Ordinary Shares or Warrants, as applicable, in other circumstances,
in which case the donees, pledgees, transferees, distributees, designees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.
In connection with
the sale of Ordinary Shares or Warrants or interests therein, the Selling Securityholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn engage in short sales of Ordinary Shares or Warrants in the course
of hedging the positions that they assume. The Selling Securityholders may also sell Ordinary Shares or Warrants short and deliver
these securities to close out its short positions, or loan or pledge Ordinary Shares or Warrants to broker-dealers that in turn
may sell these securities. The Selling Securityholders may also enter into option or other transactions with broker-dealers or
other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other
financial institution of Ordinary Shares or Warrants offered by this prospectus, which securities such broker-dealer or other financial
institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).
The aggregate proceeds
to each Selling Securityholder from the sale of Ordinary Shares or Warrants, as applicable, offered by it will be the purchase
price of the Ordinary Shares or Warrants, as applicable, shares less discounts or commissions, if any. The Selling Securityholders
reserve the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase
of Ordinary Shares or Warrants to be made directly or through agents. We will not receive any of the proceeds from these sales.
The Selling Securityholders
also may resell all or a portion of the Ordinary Shares or Warrants, as applicable, in open market transactions in reliance upon
Rule 144 under the Securities Act, if available, provided that such Selling Securityholder meets the criteria and conforms to the
requirements of that rule.
Any underwriters,
broker-dealers or agents that participate in the sale of Ordinary Shares, Warrants or interests therein may be deemed to be “underwriters”
within the meaning of Section 2(a)(11) of the Securities Act. Any discounts, commissions, concessions or profit that it earns on
any resale of the Ordinary Shares or Warrants may be deemed to be underwriting discounts and commissions under the Securities Act.
Anyone who is deemed to be an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act may be subject
to certain statutory liabilities as underwriters under the Securities Act.
In order to comply
with the securities laws of some states, if applicable, the Ordinary Shares and Warrants may be sold in those jurisdictions only
through registered or licensed brokers or dealers. In addition, in some states Ordinary Shares and Warrants may not be sold unless
they have been registered or qualified for sale or an exemption from registration or qualification requirements is available and
is complied with.
We have informed the
Selling Securityholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of Ordinary
Shares and Warrants in the market and to the activities of the Selling Securityholders and their affiliates. In addition, we will
make copies of this prospectus available to the Selling Securityholders for the purpose of satisfying any applicable prospectus
delivery requirements of the Securities Act. The Selling Securityholders may indemnify any broker-dealer that participates in transactions
involving the sale of the Ordinary Shares and Warrants against certain liabilities, including liabilities arising under the Securities
Act.
There can be no assurance
that the Selling Securityholders will sell any or all of Ordinary Shares or Warrants covered by this prospectus.
SELLING
SECURITYHOLDERS
This prospectus
relates to the proposed sale from time to time of up to 310,000 of our Ordinary Shares, up to 150,000 Warrants issued to the
Selling Securityholders named in the table below and the proposed sale from time to time by the Selling Securityholders of up
to 150,000 Ordinary Shares issuable upon exercise of the Warrants. We have filed the registration statement of which this prospectus
forms a part in order to permit the Selling Securityholders to offer these Ordinary Shares and Warrants, as applicable, for
resale or transfer from time to time as set forth above in “Plan of Distribution”.
The following table
sets forth certain information regarding the Selling Securityholders and their beneficial ownership of our Ordinary Shares and
Warrants. The table is based upon information provided by the Selling Securityholders. The table assumes that all the Ordinary
Shares and Warrants being offered by the Selling Securityholders pursuant to this prospectus are ultimately sold in the offering.
The Selling Securityholders may sell some, all or none of their Ordinary Shares or Warrants covered by this prospectus, and as
a result the actual number of Ordinary Shares or Warrants that will be held by the Selling Securityholders upon termination of
the offering may exceed the minimum number set forth in the table. The address of each Selling Securityholder is C/O Akazoo S.A.,
One Heddon Street, W1B 4BD, London, UK. Unless otherwise noted below all beneficial ownership reflected in the following table
is direct beneficial ownership.
|
Name
of Selling Shareholder
|
|
Ordinary
Shares Beneficially Owned Prior to the Offering
|
|
|
Percentage
of Ordinary Shares Ownership Prior to the Offering (1)
|
|
|
Warrants
Beneficially Owned Prior to the Offering
|
|
|
Percentage
of Warrant Ownership Prior to the Offering (2)
|
|
|
Total
Ordinary Shares Offered Hereby
|
|
|
Ordinary
Shares Beneficially Owned Following the Offering
|
|
|
Percentage
of Ordinary Shares Ownership Following the Offering (1)
|
|
|
Total
Warrants Offered Hereby
|
|
|
Warrants
Beneficially Owned Following the Offering
|
|
|
Percentage
of Warrants Ownership Following the Offering (2)
|
|
|
David E
Campbell and Michelle A Campbell (3)
|
|
|
310,000
|
|
|
|
*
|
|
|
|
150,000
|
|
|
|
2.0
|
|
|
|
310,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
150,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1)
|
Based on an aggregate of 49,735,210 Ordinary Shares outstanding.
|
|
|
(2)
|
Based on an aggregate of 7,320,000 Warrants outstanding.
|
|
|
(3)
|
Consists of Ordinary Shares and Warrants beneficially owned and held jointly with right of survivorship
by David E. Campbell and Michelle A. Campbell who are, jointly, Selling Securityholders in this offering.
|
EXPENSES
The following are
the estimated expenses of the issuance and distribution of the securities being registered under the registration statement of
which this prospectus forms a part, all of which will be paid by us.
|
Commission registration fee
|
|
$
|
300
|
|
|
Legal fees and expenses
|
|
$
|
10,000
|
|
|
Accounting fees and expenses
|
|
$
|
5,500
|
|
|
Miscellaneous
|
|
$
|
1,000
|
|
|
Total
|
|
$
|
16,800
|
|
LEGAL
MATTERS
The validity of the
securities offered by this prospectus will be passed upon for us by Norton Rose Fulbright Luxembourg SCS, Luxembourg counsel to
Akazoo.
EXPERTS
The audited financial
statements of Old Akazoo and its subsidiaries as of December 31, 2018, 2017 and 2016 and the related consolidated statements of
profit or loss and other comprehensive income, changes in equity and cash flows for each of the three years in the period ended
December 31, 2018, 2017 and 2016 are incorporated by reference to such financial statements filed by Akazoo with the Commission
on a Shell Company Report on Form 20-F on September 17, 2019. Such financial statements have been audited by Crowe U.K. LLP, an
independent registered public accounting firm as stated in their report appearing in the financial statements and is incorporated
by reference upon reliance of the report of such firm given upon their authority as experts in accounting and auditing.
The balance sheets
of MMAC as of March 31, 2019 and 2018, the related statements of operations, changes in stockholders’ equity and cash flows,
for the years ended March 31, 2019, 2018 and 2017 are incorporated by reference to such financial statements filed by Akazoo with
the Commission on a Shell Company Report on Form 20-F on September 17, 2019. Such financial statements have been audited
by WithumSmith+Brown, PC, independent registered public accounting firm, as stated in their report appearing in the financial statements
and are incorporated by reference upon reliance of the report of such firm given upon their authority as experts in accounting
and auditing.
WHERE
YOU CAN FIND ADDITIONAL INFORMATION
As required by the
Securities Act, we filed a registration statement relating to the securities offered by this prospectus with the Commission. This
prospectus is a part of that registration statement, which includes additional information.
Commission Filings
We file annual and
special reports with the Commission. The Commission maintains a website (http://www.sec.gov) that contains reports, proxy and information
statements and other information regarding issuers that file electronically with the Commission.
Information Incorporated
by Reference
The Commission allows
us to “incorporate by reference” information that we file with it. This means that we can disclose important information
to you by referring you to those filed documents. The information incorporated by reference is considered to be a part of this
prospectus, and information that we file later with the Commission prior to the termination of this offering will also be considered
to be part of this prospectus and will automatically update and supersede previously filed information, including information contained
in this document.
We hereby incorporate
by reference the documents listed below and any future filings made with the Commission under Section 13(a), 13(c) or 15(d) of
the Exchange Act.
|
|
·
|
Our Reports on Form 6-K filed with the Commission on
September
11, 2019, September
27, 2019 (which includes interim financial statements for the three and six month periods ended June 30, 2019 and June 30,
2018), November
25, 2019, December
9, 2019, February
25, 2020, February
27, 2020 and March 24, 2020.
|
|
|
·
|
The description of Ordinary Shares contained in our registration
statement on Form
F-4 (File No. 333-229613), including any subsequent amendments or reports filed for the purpose of updating that description.
|
We are also incorporating
by reference all subsequent Annual Reports on Form 20-F that we file with the Commission and certain reports on Form 6-K that we
furnish to the Commission after the date of this prospectus (if they state that they are incorporated by reference into this prospectus),
including all such reports filed after the date of the initial registration statement and prior to effectiveness of the registration
statement, until we file a post-effective amendment indicating that the offering of the securities made by this prospectus has
been terminated. In all cases, you should rely on the later information over different information included in this prospectus
or the applicable prospectus supplement.
You should rely only
on the information contained or incorporated by reference in this prospectus and any accompanying prospectus supplement. Neither
we nor the Selling Securityholders have authorized any other person to provide you with different information. If anyone provides
you with different or inconsistent information, you should not rely on it. The Selling Securityholders are not making an offer
to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing
in this prospectus and any accompanying prospectus supplement as well as the information we previously filed with the Commission
and incorporated by reference, is accurate as of the dates on the front cover of those documents only. Our business, financial
condition and results of operations and prospects may have changed since those dates.
You may request a
free copy of the above-mentioned filings or any subsequent filing we incorporate by reference into this prospectus by writing or
telephoning us at the following address:
Akazoo S.A.
Attn: Corporate Secretary
One Heddon Street
W1B 4BD, London, UK
+44 20 8057 6555
Information Provided
by the Company
We maintain an internet
website at https://www.akazoo.com/. The information contained on or accessible through our website is not incorporated by reference
and is not part of this prospectus.
We will furnish holders
of our ordinary shares with annual reports containing audited financial statements and a report by our independent registered public
accounting firm. As a “foreign private issuer,” we are exempt from the rules under the Exchange Act prescribing the
furnishing and content of proxy statements to Securityholders. While we furnish proxy statements to Securityholders in accordance
with the rules of the Nasdaq Capital Market, those proxy statements may not conform to Schedule 14A of the proxy rules promulgated
under the Exchange Act. In addition, as a “foreign private issuer,” our officers and directors are exempt from the
rules under the Exchange Act relating to short swing profit reporting and liability.
PART II
INFORMATION NOT REQUIRED IN THE PROSPECTUS
|
|
Item 8.
|
Indemnification of Directors and Officers.
|
Akazoo’s articles
of association provide that directors and officers, past and present, will be entitled to indemnification from Akazoo to the fullest
extent permitted by Luxemburg law against liability and all expenses reasonably incurred or paid by him or her in connection with
any claim, action, suit, or proceeding in which he or she would be involved by virtue of his or her being or having been a director
or officer and against amounts paid or incurred by him or her in the settlement thereof. However, no indemnification will be provided
against any liability to Akazoo’s directors or officers (i) by reason of willful misfeasance, bad faith, gross negligence,
or reckless disregard of the duties of a director or officer, (ii) with respect to any matter as to which any director or officer
shall have been finally adjudicated to have acted in bad faith and not in Akazoo’s interest, or (iii) in the event of a settlement,
unless approved by a court of competent jurisdiction or the board of directors.
Furthermore, the directors
and officers of Akazoo have entered into, or will enter into, indemnification agreements with Akazoo. Under such agreements, the
directors and officers will be entitled to indemnification from Akazoo to the fullest extent permitted by Luxemburg law against
liability and expenses reasonably incurred or paid by him or her in connection with any claim, action, suit, or proceeding in which
he or she would be involved by virtue of his or her being or having been a director or officer and against amounts paid or incurred
by him or her in the settlement thereof.
Luxembourg law permits
Akazoo to keep directors indemnified against any expenses, judgments, fines and amounts paid in connection with liability of a
director towards Akazoo or a third party for management errors i.e., for wrongful acts committed during the execution of the mandate
(mandat) granted to the director by Akazoo, except in connection with criminal offenses, gross negligence or fraud. The rights
to and obligations of indemnification among or between Akazoo and any of its current or former directors and officers are generally
governed by the laws of Luxembourg and subject to the jurisdiction of the Luxembourg courts, unless such rights or obligations
do not relate to or arise out of such persons’ capacities listed above. Although there is doubt as to whether U.S. courts
would enforce this indemnification provision in an action brought in the United States under U.S. federal or state securities laws,
this provision could make it more difficult to obtain judgments outside Luxembourg or from non-Luxembourg jurisdictions that would
apply Luxembourg law against Akazoo’s assets in Luxembourg.
A list of exhibits
included as part of this registration statement is set forth in the Exhibit Index which immediately precedes such exhibits and
is incorporated herein by reference.
The undersigned registrant
hereby undertakes:
(a) (1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement unless
the information required to be included in a post-effective amendment by the undertakings below is contained in reports filed with
or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Exchange Act of 1934 that are incorporated
by reference in the registration statement, or is contained in a form of a prospectus filed pursuant to Rule 424(b) that is part
of the registration statement;
(i) To include any
prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended;
(ii) To reflect in
the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set
forth in the “Calculation of Registration Fee” table in the effective registration statement;
(iii) To include any
material information with respect to the plan of distribution not previously disclosed in the registration statement or any material
change to such information in the registration statement.
(2) That, for the purpose
of determining any liability under the Securities Act of 1933, as amended, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3) To remove from
registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
(4) To file a post-effective
amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of
any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3)
of the Act need not be furnished, provided, that the registrant includes in the prospectus, by means of a post-effective amendment,
financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information
in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect
to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information
required by Section 10(a)(3) of the Securities Act of 1933 or Rule 3-19 under the Securities Act of 1933 if such financial statements
and information are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section
13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3.
(5) That, for the purpose
of determining liability under the Securities Act of 1933, as amended, to any purchaser, each prospectus filed pursuant to Rule
424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or
other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement
as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of
the registration statement or made in any such document immediately prior to such date of first use.
(6) That, for the purpose
of determining liability under the Securities Act of 1933, as amended, to any purchaser in the initial distribution of the securities,
the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this Registration
Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or
sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser
and will be considered to offer or sell such securities to such purchaser:
(i) Any preliminary
prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(ii) Any free writing
prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;
(iii) The portion
of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and
(iv) Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser.
(b) The undersigned
registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the
registrant’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934)
that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
(c) — (g) Not
applicable.
(h) Insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the
registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
Act of 1933 and will be governed by the final adjudication of such issue.
(i) - (k) Not applicable.
SIGNATURES
Pursuant to the requirements
of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form F-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in London, United Kingdom on March 25, 2020.
|
|
AKAZOO S.A.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Apostolos N. Zervos
|
|
|
|
|
Apostolos N. Zervos
|
|
Pursuant to the requirements
of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities
indicated on March 25, 2020.
|
Signature
|
|
Title
|
|
|
|
|
|
/s/ Apostolos Zervos
|
|
Chief Executive Officer and Director
|
|
Apostolos Zervos
|
|
(Principal Executive Officer)
|
|
|
|
|
|
/s/ Pierre Schreuder
|
|
Chief Financial Officer
|
|
Pierre Schreuder
|
|
(Principal Financial Officer and Principal Accounting Officer)
|
|
|
|
|
|
*
|
|
Chairman of the Board of Directors
|
|
Lewis W. Dickey, Jr.
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
Maja Lapcevic
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
Athan Stephanopoulos
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
David Roche
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
Alexander Macridis
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
Panagiotis Dimitropoulos
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
Asit Mehra
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
Colin Miles
|
|
|
|
|
|
|
|
*By
|
/s/ Apostolos Zervos
|
|
Director
|
|
|
Apostolos Zervos, Attorney in Fact
|
|
|
AUTHORIZED
REPRESENTATIVE
Pursuant to the
requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative of the Registrant
in the United States, has signed this registration statement, in the City of Atlanta, State of Georgia, on
March 25, 2020.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Lewis W. Dickey, Jr.
|
|
|
|
|
Name: Lewis W. Dickey, Jr.
|
|
|
|
|
Title: Chairman of the Board of Directors
|
|
Exhibit Index
|
|
(1)
|
Incorporated by reference to Exhibit 4.2 to the Company’s Report on Form 6-K, filed with
the Commission on September 11, 2019
|
Akazoo (NASDAQ:SONG)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Akazoo (NASDAQ:SONG)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
